Yue Hao

15PUBLICATIONS
47CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 01, 2025
Epidemiology and clinical characteristics of mesothelioma in the Chinese population: a multicenter study.

Shengjie Yang, Yue Hao, Ke Wang

|May 30, 2024
Poor efficacy of immune checkpoint inhibitor treatment in advanced thymic carcinoma patients with liver metastases.

Yue Hao, Manyi Xu, Xiaohong Zeng

|May 25, 2024
Pyrotinib as a salvage treatment for patients with HER-2 positive advanced lung adenocarcinoma after the progression of afatinib treatment.

Manyi Xu, Yanhua Wang, Keda Shao

|May 13, 2024
Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations.

Yanhua Wang, Manyi Xu, Ke Wang

|Apr 16, 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations.

Yanhua Wang, Jingwen Wei, Manyi Xu

|Apr 16, 2024
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment.

Ke Wang, Manyi Xu, Yanhua Wang

Pageof 3

Frequent Collaborators

6 joint publications

Chunwei Xu

5 joint publications

Wenxian Wang

4 joint publications

Yongchang Zhang

4 joint publications

Zhengbo Song